<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40962631</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1479-666X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Sep</Month><Day>16</Day></PubDate></JournalIssue><Title>The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland</Title><ISOAbbreviation>Surgeon</ISOAbbreviation></Journal><ArticleTitle>The role of Cerament&#xae; (Antibiotic impregnated bone void filler) in lower limb salvage for diabetic foot patients with osteomyelitis, a scoping review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1479-666X(25)00136-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.surge.2025.09.001</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Diabetic foot osteomyelitis (DFO) is a principal cause of non-traumatic lower limb amputation, contributing substantially to morbidity, healthcare costs, and reduced quality of life. Salvage optimization strategies have included the use of local antibiotic carriers to promote healing and reduce infection recurrence. Cerament, either G (gentamicin) or V (vancomycin), resorbable antibiotic-loaded bone graft substitute, has shown potential, but evidence has not been systematically mapped.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This scoping review aimed to map and summarize the available literature on the role of Cerament G and V in lower limb salvage among patients with DFO.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search of PubMed, Embase, the Cochrane library, and Google scholar [December 2024]. Studies reporting outcomes of Cerament G or V in the management of DFO were eligible. Data were charted according to PRISMA-ScR guidelines, focusing on study design, intervention details, and key findings.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 20 studies were identified, including [case reports, case series, retrospective reviews, and prospective cohorts]. Population within the studies ranged from 1 to 136. Reported outcomes included wound healing, eradication of infection, weight bearing, new bone formation and high antibiotic concentration without systemic toxicity. Amputation rates ranged from 2.6&#xa0;% to 25&#xa0;%. Evidence is limited by small sample sizes, heterogeneity in outcome reporting, and lack of randomized controlled trials.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Current evidence suggests that Cerament G and V may be safe and effective adjuncts for limb salvage in DFO, but high-quality comparative studies are lacking. Further research is needed to support its broader use in daily practice.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elkady</LastName><ForeName>Ramy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Beaumont Hospital, Dublin, Ireland. Electronic address: Drramyelkady86@hotmail.co.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McHugh</LastName><ForeName>Seamus</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Beaumont Hospital, Dublin, Ireland. Electronic address: Seamusmchugh@rcsi.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kheirelseid</LastName><ForeName>Elrasheid</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Beaumont Hospital, Dublin, Ireland. Electronic address: elrasheidkheirelseid@rcsi.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naughton</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Beaumont Hospital, Dublin, Ireland. Electronic address: pnaughton@rcsi.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moneley</LastName><ForeName>Daragh</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Beaumont Hospital, Dublin, Ireland. Electronic address: dmoneley@rcsi.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aly</LastName><ForeName>Sayed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Beaumont Hospital, Dublin, Ireland. Electronic address: sayedaly2@beaumont.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redmond Walsh</LastName><ForeName>Stewart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Lambe Institute for Translational Research, University of Galway, Galway, Ireland. Electronic address: stewartredmond.walsh@universityofgalway.ie.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>Surgeon</MedlineTA><NlmUniqueID>101168329</NlmUniqueID><ISSNLinking>1479-666X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amputation prevention</Keyword><Keyword MajorTopicYN="N">Antibiotic carrier</Keyword><Keyword MajorTopicYN="N">Biofilm</Keyword><Keyword MajorTopicYN="N">Bone infection</Keyword><Keyword MajorTopicYN="N">Bone regeneration</Keyword><Keyword MajorTopicYN="N">Bone void filler</Keyword><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">Diabetic foot</Keyword><Keyword MajorTopicYN="N">Diabetic foot salvage</Keyword><Keyword MajorTopicYN="N">Local antibiotic delivery</Keyword><Keyword MajorTopicYN="N">Osteomyelitis</Keyword><Keyword MajorTopicYN="N">Recurrent infection</Keyword><Keyword MajorTopicYN="N">Silo technique</Keyword></KeywordList><CoiStatement>Conflict of interest There are no conflicts of interest for any of the authors of this review.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>18</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>18</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>17</Day><Hour>21</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40962631</ArticleId><ArticleId IdType="doi">10.1016/j.surge.2025.09.001</ArticleId><ArticleId IdType="pii">S1479-666X(25)00136-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>